Related by context. All words. (Click for frequent words.) 76 Trials 68 trial 57 acai pill 55 Trial 54 clinical trials 53 tribulations Groenveld 52 eldercare evaluation 51 Phase IIIb clinical 51 multicenter clinical 50 phase IIa 50 home eldercare evaluation 49 phase IIa clinical 49 clinical trial 48 blinded randomized controlled 48 Huggins Cams Time 47 placebo controlled clinical 47 Phase IIb III 47 Keflezighi hobbled 47 nonjury trials 47 multicentre randomized controlled 47 Phase III VISTA 46 Phase III randomized controlled 46 Heplisav 46 BUB Motorcycle Speed 46 Randomized placebo controlled 46 randomized Phase IIb 46 phase Ib clinical 45 Phase Ib clinical 45 Phase III trials 45 trials RCTs 45 Trovax 45 Phase IIa trials 45 pivotal bioequivalence 45 phase IIb III 45 Phase #b/#a 45 Phase 1b clinical 45 blinded placebo controlled 45 pretrials 44 pretrial proceedings 44 phase IIb clinical 44 multicenter randomized clinical 44 unblinding 44 Clinical trials 44 Cloretazine ® 44 microbicide trials 44 LymphoStat B Phase 44 BETAS 44 VESTASYNC 44 deadlocked juries 44 AP IMPACT Credibility 44 clinical pharmacology studies 44 Dr. Jeffrey Probstfield 44 Phase 1b clinical trials 44 dose escalation clinical 44 double blinded randomized 44 HPTN 44 Phase 2b clinical trials 44 Phase III psoriasis 44 Randomized controlled 43 Cloretazine R 43 retrials 43 evidentiary hearings 43 fidaxomicin Phase 3 43 ReN# 43 Independently Dyax 43 challenger Mohsen Rezaei 43 randomized controlled clinical 43 midstage trials 43 Retrials 43 Long Lesion 43 placebo controlled trials 43 Mosquirix 43 midstage studies 43 Phase Ib 43 champion Anna Meares 43 National Poinsettia Cultivar 43 Phase Ib IIa clinical 43 Phase IIB clinical 43 iPrEx 43 EXPLORE Xa 43 Phase 2b kidney transplant 43 phase IIb 43 randomized multicentre 43 ACCORD Lipid 43 ORMD 43 Phase Ia 43 experiments 43 CUSTOM III 43 BrachySil 43 SCENESSE ® 43 Intervention Effectiveness CATIE 43 Phase Ib IIa 43 multicenter randomized controlled 42 Phase III Psoriasis 42 studies 42 specified primary endpoint 42 hearings 42 Phase IIIb 42 Clinical Antipsychotic Trials 42 multicenter trials 42 Randomised Badger Culling 42 Neuvenge 42 Phase IIb dose 42 Phase IIb trial 42 Sorafenib HCC Assessment 42 CAMMS# Phase 2 42 IMPROVE IT 42 Phase II 42 Trial Initiative LSTI 42 HOPE TOO 42 BRIM3 42 DSMB recommended 42 offshore penal colonies 42 retrial 42 ACOSOG Z# 42 multicenter clinical trials 42 RIO Diabetes 42 indicated Googol 42 tesmilifene Phase III 42 Phase 1b trial 42 Phase Ib clinical trials 42 phase IIIb 42 randomized controlled clinical trials 41 Prednisporin TM 41 Albuferon Phase 41 Phase #/#a clinical 41 oral rivaroxaban 41 phase Ib 41 STOP AF 41 hepatitis B vaccine Heplisav 41 Edwards SAPIEN valve 41 Freestyle Kayak Team 41 TQT studies 41 confirmatory clinical 41 midstage clinical trials 41 Phase III clinical trials 41 GeoVax Phase 41 tramiprosate Alzhemed TM 41 multicentre randomized 41 wiretapping racketeering 41 Phase IIa proof 41 pharmacokinetic characteristics 41 multicenter placebo controlled 41 ToGA 41 testing 41 phase 2a 41 Phase IIa clinical 41 ACTIVE W 41 randomized blinded 41 placebo controlled Phase III 41 tolevamer 41 ENDEAVOR IV clinical 41 Phase #b/#a clinical 41 cannabinor 41 Phase IIB 41 placebo controlled studies 41 PRIMO CABG 41 Phase III registrational 41 randomized clinical trials 41 Phase IIb kidney transplant 41 OvaRex 41 multicenter Phase II 41 Placebo controlled 41 clinical trials SGN 41 Trastuzumab DM1 41 CAMMS# 41 VADT 41 trialed 41 phase III ACCLAIM 41 multicentre study 41 blinded randomized placebo controlled 41 CALGB # [002] 40 Anthim 40 Thorough QT 40 studies evaluating satraplatin 40 CBLC# 40 prosecutions 40 randomized clinical 40 EMPHASIS HF trial 40 XL# SAR# 40 multicenter randomized placebo controlled 40 Phase IIb 40 SIMPADICO 40 Phase III clinical 40 HCV RESPOND 2 40 tremelimumab 40 dose escalation Phase 40 TBC M4 40 SYMMETRY trial 40 ASCEND HF 40 Varisolve 40 Phase IIIb study 40 COMFORT II 40 ENDEAVOR III 40 LabCorp conducts clinical 40 intratumoural 40 randomized controlled multicenter 40 AVADO 40 IIa clinical 40 RIO Lipids 40 IIa clinical trial 40 Phase III 40 Phase IIb clinical trials 40 budesonide foam 40 Intervention Effectiveness 40 Liprostin 40 CEQ# 40 ORBIT II 40 Network HPTN 40 NSABP C 40 VIR# 40 Phase 2a preventative 40 cellulose sulphate 40 Ereska 40 registrational Phase 40 nonjury civil 40 PEARL SC 40 GSK# [002] 40 voire dire 40 Reolysin 40 NeuroFlo 40 AERAS-#/Crucell Ad# 40 landmark ATHENA 40 randomized blinded placebo 40 Committee IDMC 40 preclinical efficacy 40 Phase #/#a 40 tribunals 40 Ditech Networks VQA 40 Phase IIa trial 40 SPIRIT FIRST 40 randomized trials 40 NSABP B 40 MADIT CRT trial 40 RSD# oral 40 bicifadine 40 Multikine ® 40 BALCO steroid probe 39 EURIDIS 39 paclitaxel poliglumex 39 TRIALS 39 Lupuzor 39 multicentre 39 Phase 2a 39 Maximum Tolerated Dose MTD 39 prospective randomized controlled 39 IP eXchange IPX 39 BRAF inhibitor 39 DASISION 39 MADIT II 39 TOLAMBA 39 Tolamba 39 AVERROES 39 thorough QT 39 Tribble ations 39 Phase lll 39 Phase IIb clinical 39 Multicenter Automatic Defibrillator Implantation 39 TG MV 39 silver medalist Emma Pooley 39 placebo controlled randomized 39 recurrent malignant glioma 39 riociguat 39 dirucotide MBP# 39 Phase Ib II 39 CUSTOM II 39 Phase 2a clinical 39 bronchial thermoplasty 39 Phase 1a 39 evaluating mipomersen 39 PFO migraine 39 cellulose sulfate 39 ganaxolone 39 SPIRIT III 39 Cogane 39 CHAMPION PCI 39 Exherin TM 39 RTS S/AS# 39 lawyer Andrew Carboy 39 blinded randomized 39 Val HeFT 39 vemurafenib 39 BNC# 39 eliglustat tartrate 39 CRD5 39 rALLy trial 39 lowering triglyceride levels 39 lomitapide 39 VNP#M 39 court martials 39 Phase 2b 39 TAXUS ATLAS Small 39 Phase IIa 39 Phase IIa clinical trials 39 dose escalation trial 39 FlutiformTM 39 Phase 2b study 39 placebo controlled multicenter 39 ABSORB trial 39 myoblast therapy 39 femtocell deployments 39 phase IIb study 39 GVAX 39 harsh interrogations Guantanamo 39 UPLYSO 39 Multi MERCI 39 iii GTx 39 TASKi3 39 GSMA IPX 39 olaparib 39 bardoxolone 39 drug Recentin 39 competency evaluations 39 Raloxifene STAR 39 Ushercell 39 ADVANCE PD 39 EVA 3S 39 OncoVex 39 Additionally Nexavar 39 Tykerb lapatinib 39 blind randomized controlled 39 O2 Wallet 39 Vectibix panitumumab 39 Telcyta 39 Land Rover Burghley Horse 39 trialing 39 SYMMETRY SM trial 39 NO# [002] 39 ENRICH trial 38 placebo controlled Phase 38 dose regimens 38 PRIMO CABG2 38 double blinded placebo 38 HIVNET 38 PRECISE Trial 38 designated HVTN 38 rALLy 38 Phase 1a clinical 38 RhuDex 38 Onglyza saxagliptin 38 Tocosol 38 Phase 2b trial 38 randomized controlled 38 CRLX# 38 GLP toxicology studies 38 AIDSVAX flunked 38 Urocidin 38 MitoQ 38 TGN# 38 trastuzumab DM1 38 toxicological studies 38 placebo controlled 38 laninamivir 38 phase IIb trial 38 Cytolin R 38 optimal dosing 38 rotary VAD 38 Corlux 38 TBC# 38 SORT OUT III 38 TAXUS ATLAS 38 prospective randomized placebo 38 DIABECELL R 38 isavuconazole 38 ORAL Sync 38 MIST II 38 efficacy 38 Pre RELAX AHF 38 military tribunals 38 AIR inhaled insulin 38 ONTARGET R 38 Prostate Cancer Prevention 38 BLOOM DM 38 Viveta 38 ONTARGET 38 treatment naive genotype 38 TEC #OL 38 multicenter phase 38 IIa trials 38 Meta analyzes 38 Phase III confirmatory 38 SPIRIT IV 38 vitro dissolution 38 OvaRex ® MAb 38 CLARITY TIMI 38 NP2 Enkephalin 38 afamelanotide 38 HCV SPRINT 38 ANCHOR trial 38 Provenge prostate cancer 38 Neo Bladder Augment 38 Prodarsan 38 BEZ# 38 investigations 38 pharmacokinetic studies 38 pediatric glioma 38 Pretrial hearings 38 blind multicenter 38 LibiGel Phase III 38 dosage regimens 38 TELCYTA 38 GM herbicide tolerant 38 Alzhemed 38 Swimvitational 38 RE MODEL 38 COR Diabetes 38 Onalta ™ 38 Zilver PTX 38 Geotextile tubes 38 SEPET TM 38 IIa clinical trials 38 courts martial 38 Novo TTF 38 Lithuania Simona Krupeckaite 38 Omapro 38 Confirmatory tests 38 WHIMS 38 VITAL Trial 38 controlled multicenter 38 Phase 2a trial 38 IMPACT DCM clinical 38 pretrial hearings 38 RE LY ® 38 Vorapaxar 38 CV Therapeutics Nasdaq CVTX 38 Novartis Zometa 38 WX UK1 38 multicenter prospective 38 DAPT 38 Voir dire 37 Ateronon 37 Aidsvax 37 acyclovir Lauriad R 37 drought tolerant corn 37 ENGAGE AF TIMI 37 dose pharmacokinetic 37 neratinib 37 OLYMPIA registry 37 randomized multicenter Phase III 37 placebo controlled clinical trials 37 inquests 37 thin cirrus clouds 37 confirmatory Phase III 37 Pivotal Trial 37 Asentar 37 multicenter Phase 37 initiate Phase 2b 37 blind multicentre 37 trastuzumab Herceptin ® 37 confirmatory Phase 3 37 bioequivalence studies 37 randomized controlled trial 37 Dave Tucek 37 AERAS 37 TransMID 37 cervical cancer vaccine Cervarix 37 PSN# [002] 37 HGS# 37 intravenous dosing 37 National Emphysema Treatment 37 dosing cohorts 37 Phase IIb trials 37 lawyer Michalis Dimitrakopoulos 37 EchoCRT 37 ENDEAVOR II 37 Genous 37 myopic CNV 37 European Sepsis Trial 37 TAXUS IV 37 Vertex hepatitis C 37 incyclinide 37 tanespimycin 37 preparticipation screening 37 OBPM 37 denosumab oncology 37 jumpouts 37 RECORD1 37 Nanocort 37 REALITY Trial 37 Allovectin 7 R 37 e2 Collector 37 Diplock courts 37 tests 37 ADAGIO study 37 Adis Medunjanin awaits 37 UKPDS 37 DEEP AF 37 carcinogenicity study 37 ENESTnd 37 Board DSMB 37 CURRENT OASIS 7 37 Amoxicillin PULSYS Phase III 37 FM VP4 37 multicenter Phase III 37 clinicaltrials.gov 37 aleglitazar 37 Phase #b/#a trial 37 epidural steroids 37 candidates Dyloject TM 37 Archexin 37 DXL# 37 CATIE AD 37 dose escalation phase 37 relapsing remitting MS RRMS 37 randomized placebo controlled 37 #mg ATC 37 Phase IIA 37 LUVENIQ 37 masked placebo controlled 37 Sibutramine Cardiovascular Outcomes 37 bioequivalency 37 bile duct tumor 37 PERSEUS 37 prospective observational 37 GLPG# 37 gacaca courts 37 Batten afflicted 37 GeoVax vaccine 37 Advagraf 37 IMPACT DCM 37 Phase 2a clinical trials 37 Dose escalation 37 carotid stents 37 PreCISe 37 Edge STudy 37 ganetespib 37 Bt rice 37 Cloretazine R VNP#M 37 PLCO 37 AIR CF1 37 criminal prosecutions 37 EDEMA3 37 Xyotax 37 drug NP2 Enkephalin 37 ALK inhibitors 37 pharmacokinetic PK study 37 treating enlarged prostates 37 TheraCIM h R3 37 AE# vaccine 37 trastuzumab emtansine T DM1 37 telaprevir dosing 37 Bexion 37 IIa trial 37 jury nobbling 37 DiabeCell 37 spokeswoman Margarete Noetzel 37 drug TGN# 37 vaccine Stimuvax 37 RCTs 37 NSABP 37 LC#m# 37 hung juries 37 champion Brimin Kipruto 37 Subgroup analysis 37 PCA3 test 37 adjudicatory hearings 37 antibiotic Trovan 37 arzoxifene 37 subanalysis 37 galiximab 37 neurologic progression 37 recurrent metastatic 37 Cannabinor 37 Elocalcitol 37 doxorubicin docetaxel 37 SUCCEED trial 37 MyVax 37 identifier NCT# 36 Orexigen Contrave 36 Prostate Lung Colorectal 36 Tocosol Paclitaxel 36 dose cohorts 36 TRAIL receptor antibody mapatumumab 36 NVA# 36 AIM HIGH 36 GRNVAC1 36 IND Investigational New 36 tamoxifen therapy 36 Onconase 36 TQ Micro 36 ralfinamide 36 Rezonic 36 Lm vaccine 36 DEB# 36 Phase III Clinical Trials 36 Taxus Liberte 36 pertuzumab 36 MADIT 36 paroxetine Seroxat 36 prospective randomized 36 CCR2 antagonists 36 modified REGENESIS Phase IIb 36 Polyp Prevention Trial 36 multicenter 36 Firecracker Futurity 36 ABSORB clinical 36 prospective randomized multicenter 36 randomized Phase III 36 Agress TM 36 Phase IIb REGENESIS 36 genetically altered alfalfa 36 rotavirus vaccine RotaTeq 36 inecalcitol 36 Ovarian Cancer Screening 36 CALGB 36 MS spasticity 36 Oglemilast 36 Ragweed Allergy 36 IND CTA 36 opioid naive 36 ASSERT trial 36 randomized #:#:# 36 Anturol TM 36 davunetide intranasal AL 36 ACV1 36 LymphoStat B TM 36 Raptiva ® 36 arraignments 36 prospective observational studies 36 Zactima 36 Maxine Waters D Calif 36 ragweed allergy immunotherapeutic 36 oral ridaforolimus 36 Phase III TRIST 36 CCR5 inhibitor 36 Daniel Fransen 36 Zemplar Capsules 36 Vacc 4x 36 Si Mi 36 randomized controlled trials 36 APEX PD 36 randomized multicenter 36 harmless vertigo 36 BST CarGel R 36 investigational protease inhibitor 36 Burkina Faso Gabon 36 elacytarabine 36 Motesanib 36 Galvus vildagliptin 36 GeoVax HIV AIDS 36 Gene Therapy Advisory 36 MAGE A3 ASCI 36 Pfizer Selzentry 36 www.ingenuity.com 36 TAXUS VI 36 Bronchitol 36 PROSTVAC TM 36 postmarketing studies 36 NCT# ClinicalTrials.gov 36 Raloxifene Evaluation MORE 36 CWID 36 includes TOLAMBA TM 36 Zoraxel 36 Phase III pivotal 36 iPrEx study 36 Rheos System 36 testing IOT 36 EGS# 36 Rubicon Filter 36 juries 36 HF ACTION 36 SRT# [003] 36 Vaxine 36 Alfimeprase 36 canagliflozin 36 double blind placebo 36 Dendreon Provenge 36 demonstrated antitumor activity 36 multicentre randomized double 36 axitinib 36 ICA # 36 KRN# 36 defendant Vincenzo Cannalire 36 oral deforolimus 36 Epanova 36 randomized controlled Phase 36 Phase III randomized 36 Canvaxin 36 biochemical assays 36 ENHANCE trial 36 Atu# 36 including eniluracil ADH 36 PREVENT IV 36 rollouts 36 premarketing 36 GSK# [001] 36 MyVax personalized immunotherapy 36 postapproval 36 Aryplase 36 motesanib 36 multidose 36 gepirone ER 36 recurrent glioma 36 Diving Trials 36 abiraterone 36 OncoVEX GM CSF 36 PANVAC VF 36 nonclinical studies 36 ACCEDE 36 Trial SELECT 36 Xelox 36 MIRCERA 36 EndoTAG TM -1 36 PRX # 36 cetrorelix pamoate 36 canakinumab 36 Cangrelor 36 Company proprietary INACTINE 36 Phase III placebo controlled 36 Pretrial motions 36 Vaxfectin TM 36 dose escalation 36 CLARITY study 36 ERSPC 36 treat premature ejaculation 36 MADIT CRT 36 ProLindac 36 Multimeric 36 albiglutide 36 proceedings 36 Sutent sunitinib 36 RESOLUTE 36 randomized multicenter trial 36 MEND CABG 36 Judge Carol Higbee 36 ALSYMPCA 36 alvespimycin 36 Exelixis compounds 36 molecular chaperone regulator 36 OHR/AVR# 36 lorcaserin Phase 36 DIABECELL 36 dosage regimen 36 Cinquil 36 postwar Nuremberg 36 valopicitabine 36 blood thinner prasugrel 36 Nimotuzumab 36 multicenter randomized 36 Dacogen injection 36 anastrazole 36 Medidata Designer 36 novel VDA molecule 36 GSM1x 36 multiple ascending dose 36 viral kinetic 36 VersaFilm 36 ataluren 36 Gabapentin GR 36 dosing regimens 36 telcagepant 36 Randomised 36 blood clot preventer 36 trastuzumab DM1 T DM1 36 meter freestyles 36 GALNS 36 reactogenicity 36 retapamulin 36 Bicester Magistrates Court 36 confirmatory Phase 36 eosinophilic asthma 36 solanezumab 36 testings 36 Levacor 36 Cordis Cypher stent 36 clinical 36 blind randomized 36 BLA filing 35 phase III isavuconazole 35 VentrAssist 35 docetaxel Taxotere ® 35 randomized crossover 35 HCV protease inhibitors 35 phase III SIMPADICO 35 SCD HeFT 35 PD2i CA 35 MedPulser ® 35 Medidur TM FA 35 WHI Dietary Modification 35 combination REOLYSIN 35 temsirolimus 35 topical testosterone 35 labial herpes 35 metastatic hormone refractory 35 Pulminiq 35 Pagoclone 35 Eniluracil 35 breast cancer recurrences 35 carotid stent 35 Fodosine 35 Dextofisopam Phase 2b 35 Tangshan Yian 35 GENASIS clinical 35 Pfizer maraviroc 35 Endeavor DES 35 multicenter study 35 intravenous cyclophosphamide 35 vitro experiments 35 Inovio electroporation 35 ToleroMune 35 tesofensine 35 mapatumumab 35 Serono Rebif 35 AIR CF2 35 taspoglutide 35 Study ADCS 35 Lovaxin C 35 hypercholesterolemic patients 35 fosbretabulin 35 Athens Olympics 35 Diamyd r vaccine 35 CVBT #H 35 bioabsorbable stent 35 HuMax CD#b 35 SAR# [004] 35 refractory prostate cancer 35 Mitsubishi Motors Badminton Horse 35 ticagrelor Brilinta 35 herbicide tolerant 35 CB2 selective receptor agonist 35 activating EGFR mutations 35 number NCT# ClinicalTrials.gov 35 rALLy clinical trial 35 clinical trials Archexin ® 35 NCCTG 35 hESC derived RPE cells 35 eventing competitions 35 Dougie Lampkin 35 USDAA 35 late onset Pompe 35 silver medalist Thanou 35 CSRTs 35 REOLYSIN ® 35 executions 35 prospective multicenter 35 Lisbeth Lenton 35 vaginal microbicide 35 CURE AF 35 DSMB 35 adipiplon 35 ancrod 35 rBChE 35 SCY 35 unblind 35 Arimoclomol 35 Pimavanserin 35 Endoscopic Ablation System 35 Telintra 35 RE LY 35 landmark ATHENA study 35 clinical trials Archexin 35 Probuphine 35 Novitzky recounted 35 Prostate AdenoCarcinoma Treatment 35 vosaroxin 35 Summations 35 mg administered orally 35 EmbraceAC 35 AOD# [002] 35 coach Grant Stoelwinder 35 GLP toxicology 35 subgroup analyzes 35 SUTENT ® 35 OMP #M# 35 Bahrain Rashid Ramzi 35 DiabeCell R 35 DCVax ® Brain 35 PRESEPT study 35 methodologically rigorous 35 Pfizer inhaled insulin 35 NexACT 35 Hyphanox 35 Orazol 35 resentencings 35 MMP inhibitors 35 Carraguard 35 CARE HF 35 Fentanyl TAIFUN R 35 PHT ePRO System 35 TOCOSOL Paclitaxel 35 lasofoxifene 35 refractory CLL 35 handovers 35 GAMMAGARD 35 assessing T DM1 35 olanzapine LAI 35 intravenous infusions 35 XP #L 35 ularitide 35 YONDELIS 35 VaxGen AIDSVAX 35 observational studies 35 AQUAVAN R 35 Oral Insulin Capsule 35 Saxagliptin 35 Alpha Tocopherol Beta Carotene 35 Pivotal Clinical Trial 35 Teflaro 35 Serada 35 LUMINATE 35 TACI Ig 35 AVN# Phase 35 Veterinarian Manual 35 Initiated Phase 35 Alequel 35 Diamyd ® 35 Provacel 35 LCP AtorFen 35 HVTN 35 investigational 35 ONCONASE R 35 CytoFab ™ 35 bioequivalency studies 35 multicenter randomized double 35 REMEDIAL II 35 rimonabant Acomplia 35 subcutaneous PRO 35 Valtropin 35 Delcath Phase III 35 antibiotic telavancin 35 fund BioSante LibiGel 35 OvaRex MAb 35 Allovectin 7 ® 35 LabCorp conducts clinical trials 35 Twinrix 35 candidate CRLX# 35 ClosureFAST catheter 35 masitinib 35 Mr. Miloševic 35 badger culls 35 MKC# PP 35 dose escalation study 35 ruxolitinib 35 Clinical Outcomes Utilizing Revascularization 35 cluster randomized controlled 35 preclinically 35 nonrandomized 35 IIb clinical trial 35 evaluating satraplatin plus 35 TMC# C# 35 blind randomized placebo 35 ENDEAVOR IV 35 PrevOnco 35 Cholesterol Levels SPARCL 35 TriGrid 35 DIABECELL ® 35 SILENOR 35 champion Fabian Cancellara 35 generation PNP inhibitor 35 REMUNE R 35 Retrial 35 ADONIS 35 PSMA ADC 35 tezampanel NGX# 35 ocrelizumab 35 adjuvant colon cancer 35 Phase 2b dose 35 maximally tolerated dose 35 ISEL 35 PF # [002] 35 TAXUS V 35 CDK inhibitors 35 Lucanix R 35 epothilone KOS 35 randomized controlled trials RCTs 35 cyclophilin inhibitors 35 tezampanel 35 Pfizer torcetrapib 35 active comparator 35 prove exculpatory inculpatory 35 intravenous picoplatin 35 Augment Injectable 35 kilometer prologue 35 immunological diseases 35 Ophena 35 Endeavor drug eluting 35 CHAMPION PLATFORM 35 rPA anthrax vaccine 35 iSONEP 35 Mylotarg 35 Arraignments 35 acute HAE attacks 35 CytoFabTM 35 meta analysis pooling 35 http:/www.investorsobserver.com/MUQuote2 35 Cytolin ® 35 ANAVEX #-# [001] 35 coxib 35 Spain Josephine Onyia 35 lenalidomide Revlimid R 35 RPL# 35 Phase 35 CCR5 antagonist 35 Scandinavian Cardiac Outcomes 35 Syncria 35 hypoxia activated prodrug 35 ozarelix 35 resminostat 35 mipomersen